. Author manuscript; available in PMC: 2013 Jan 8.

Published in final edited form as: Ophthalmology. 2011 Dec;118(12):2480–2486. doi: 10.1016/j.ophtha.2011.05.024

Table 1.

Baseline Patient Demographics and Follow-up Period

Demographic	No. (% of Total)^*
Eyes included	135 eyes of 133 patients
	Left: 64 (47.4)
	Right: 73 (54.1)
Diagnosis, eyes	Retinoblastoma 128 (94.8)
	Medulloepithelioma 3 (2.2)
	Other (non-trauma) 3 (2.2)
Disease process, patients	Unilateral 91 (68.4)
Disease process, patients	Bilateral 42 (31.6)
Age at enucleation, yrs	Median 2.2, range 0.2–9
Age at enucleation, yrs	Mean 2.5±1.8
Race, patients	Caucasian: 75 (56.4)
	African American: 39 (29.3)
	Hispanic: 15 (11.3)
Gender, patients	Male 71 (53.4)
Gender, patients	Female 62 (46.6)
Time, diagnosis to enucleation	Median: 5 days, range 0–7.7 yrs
Time, diagnosis to enucleation	Mean: 0.5±1.0 yrs
Follow-up	Median: 3.6, range 0.1–9.3 yrs
Follow-up	Mean: 3.9±2.4 yrs

Unless otherwise indicated.